Brief Reports Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 15, 2000; 6(4): 553-556
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.553
Study on the risk factors of lymphatic metastasis and the indications of less in vasive operations in early gastric cancer
Bo-Jian Jiang, Rong-Xun Sun, Hao Lin, You-Fu Gao, Department of General Surgery, Shanghai Jing-An Central Hospital, Shanghai 200040, China
Bo-Jian Jiang, male, Born on 1958-02-08 in Shanghai, graduated from Shanghai Second Medical University for M.D. in 1983 and Asahikawa Medical College for Ph.D. in 1996, now an Associate Professor/Vice Chairmen, Dept. of General Surgey, Jing-An Central Hospital, Shanghai, majoring in gastrointestinal oncology, hepatocyte transplantation, and having 30 papers published.
Author contributions: All authors contributed equally to the work.
Correspondence to: Bo-Jian Jiang, MD., Dept of General Sur gery, Shanghai Jing-An Central Hospital, No 259, Xi-Kang Road, Shanghai 200040, China
Telephone: +86-21-62474530, Ext. 6009
Received: February 28, 2000
Revised: May 12, 2000
Accepted: June 2, 2000
Published online: August 15, 2000

Abstract
Key Words: stomach neoplasms/diagnosis, neoplasm metastasis, precancerous conditions, risk factors, surgery/operative, lymphatic metastasis, lymph node excision



INTRODUCTION

The principle of surgical treatment for gastric cancer is the radical resectioni ng although the suitable resecting range for different cases of gastric cancer is still being argued upon[1-9]. However, the diagnostic accuracy of early gastric cancer (EGC) without lymphatic metastasis has obviously improved with an improvement in the diagnostic technique and due to the accumulation of kn owledge on the biological profiles of EGC[10-17]. The D2 lymph node excision was used as a regular operation to treat the EGC previously. But the concept for the EGC without lymphatic metastasis has gradually changed and the less invasive resections has been applied in some cases[18-20]. This study aimed at investigating the risk factors of lymphatic metastasis in EGC in order to find out the proofs for the suitable indications for less invasive operations such as endoscopic mucosal resectioning (EMR), laparoscopic and laparotomic res ectioning.

MATERIALS AND METHODS

From 1978 to 1999, 520 cases of EGC with operative and pathological analyses were studied. Among them, 287 were male and 233 female, with an average age of 62 years (32-81). The samples from the primary tumor and the metastatic lymph nodes were collected and examined as previous reports distinguishing the tumor was limited in mucosal layer (m Ca) or submucosal layer(sm Ca) of stomach[10] were scanty. According to the gross differences of the following groups were constituted of IIc + III, IIc, IIb, IIa and I.

Sixty-six cases diagnosed by the ultrasound endoscopical examination received t he less invasive operative technique. This resection retained the partial omentu m and resected the 1st station and No 7 of lymph nodes. In this operation, the dissection was made and the omentum was cut off in (3-4) cm places away from or along the blood vessels in greater and less curvature of the stomach. And the No 7 lymph nodes were resected and blocked or picked out. Hepatic branch of vagus had better to be protected possibly. Mouth margin and anal margin for gastr ectomy was over 2 cm away from the tumor site. All of 259 cases received radical resectioning of N2 lymph nodes or a more radical resection.

The rate of lymphatic metastasis and the morbidity of intestinal obstruction after operation and the expression of long-term survival were statistically analyzed by Check test or by log-rank test respectively. P value less than 0.05 was considered statistically significant.

RESULTS

In this study, the risk factors regarding the occurrence of lymphatic metastasis were investigated. The long-term survival analysis and the complications relat ing to the less invasive operation were studied at the same time.

Gross type

Lymphatic metastasis happened the most easily in IIc + III subgroups of both m Ca and sm Ca, and secondly in IIc subgroups. In IIc + III subgroups, the lymphatic metastasis could be identified in 2 cases of m Ca and 20 cases of sm Ca, and one n2 lymphatic metastasis was observed in m Ca and 10 in sm Ca (Table 1). No n2 lymphatic metastasis could be found in other subgroups of m Ca. However, this n2 lymphatic metastasis could be observed in sm Ca in all groups except IIb.

Table 1 Lymphatic metastasis relating to gross types (%).
Gross typesm Ca (n = 275)sm Ca (n = 245)
IIc + III2.5 (2/85)*,b25.3 (20/79)
IIc1.7 (2/120)b20.2 (17/84)
IIb0 (0/3)0 (0/4)
IIa + IIc0 (0/29)23.8 (10/42)
IIa0 (0/34)25.0 (2/8)
I0 (0/4)17.9 (5/28)
Invading depth

Forty-four cases of n1 lymphatic metastasis and 14 cases of n2 lymphatic metastasis (58 cases of lymphatic metastasis in total, 11.2%) could be demonstrated in all cases of EGC. Four (1.5%) of 275 cases suffering from the m Ca had lymphatic metastasis, of which one case shared n2 lymphatic metastasis (Table 2). Lymphatic metastasis was identified in 54 (22.0%) out of 245 cases in sm Ca group, of which 13 cases were of n2 lymphatic metastasis. Thi s result showed that lymphatic metastasis was more frequent in sm Ca than in m Ca (P < 0.05).

Table 2 Lymphatic metastasis relate(LMR) of m and sm Ca(%).
Invading depthn1 LMRn2 LMRTotal LMR
m Ca (n = 275)1.1 (3)*0.4 (1)1.5 (4)b
sm Ca (n = 245)16.7 (41)5.3 (13)22.0 (54)
Total cases (n = 520)8.5 (44)2.7 (14)11.2 (58)
Tumor size with or without ulcer

With tumor size less than 20 mm in m Ca, there was no lymphatic metastasis in 122 of 275 cases regardless whether accomp anied with ulcer or not. In 153 cases with tumor larger than 20 mm, there were 4 cases of lymphatic metastasis in m Ca (P < 0.01, Table 3). Among 164 cases with m Ca and without ulcer, the lymphatic metastasis cou ld be observed only in one with 25 mm of tumor. On the other hand, 3 of 111 cases of lymphatic metastasis could be found in ulcer group, in which all tumors were larger than 30 mm. These findings indicated that lymphatic metastasis was more significantly in cases with tumor size larger than 20 mm subgroups, especially those with ulcer (P < 0.05).

Table 3 Lymphatic metastasis related to tumor size with or without ulcer (%).
Ulcer diameter(cm)m Ca (n = 275)
sm Ca (n = 245)
With ulcer(n = 111)Without ulcer(n = 164)With ulcer(n = 110)Without ulcer(n = 135)
≤ 20 (0/43)0 (0/79)16.7 (3/18)3.1 (1/32)
~30 (0/21)2.4 (1/42)20.8 (5/24)21.1 (8/38)
~45.3 (1/19)0 (0/15)20.0 (4/20)24.0 (6/25)
~56.7 (1/15)0 (0/14)18.8 (3/16)18.2 (4/22)
≥ 61 (1/13)0 (0/14)43.8 (14/32)33.3 (6/18)
Total No2.7 (3/111)a0.6 (1/164)26.4 (29/110)a18.5 (25/135)

In sm Ca, 4 out of 50 (8.0%) cases of lymphatic metastasis could be identified in cases with tumor size less than 20 mm with or without ulcer, which showed that the radicalres ection with standard lymph node excision could be carried out even in small tu mor sized sm Ca.

In 135 cases of sm Ca without ulcer, 25 (8.5%) cases were demonstrated to have ly mphatic metastasis, out of which 12 (11.3%) cases belonged to n2 lymphatic meta stasis. But 29 out of 110 (26.4%) cases of sm Ca with lymphatic metastasis were prov en to occur in the ulcer subgroup, in which 7 (6.4%, P < 0.05) cases had n2 lymphatic metastasis. Therefore, the n2 lymphatic metastasis happened more sig nificantly in sm Ca than in m Ca.

Pathological classification

One hundred and forty-three out of 275 cases (52.0%) with m Ca had well-differentiatied adenocarcinoma in which there was n o lymphatic metastasis. Two out of 58 cases (3.4%) and 2 out of 57 cases (3.5%) sharing lymphatic metastasis were respectively identified in the poorly-differe ntiatied group and the non-differentiatied group of EGC. Fifty-four out of 245 (22.0%) cases with lymphatic metastasis were observed in sm Ca, out of which th ere were 21 (8.6%), 11 (4.5%), 15 (6.1%), and 7 (2.9%) cases respectively in each group of well-differentiatied, poorly-differentiatied, non-differentiatied and ringed cells cancer. Difference in pathological classification could not si g nificantly result in the increase of lymphatic metastasis, but n2 lymphatic me tastasis was more easily recognized in worst differentiatied groups.

Comparison of D2 and D1+7

resections In a study regarding the less invasive D1+7 resection, this resection and D2 or more radical lymph node excision were separately carried out in 66 cases and 259 cases during 1988-1999. All cases resulted in the curable resection and the longest follow-up was of 10 years. In D1+7 group, only one case was histopathologically demons trated for the occurrence of lymphatic metastasis. Twelve cases diagnosed as m Ca preoperatively were sm Ca and others were m Ca. In investigating the postopera tive complications, 1 out of 66 cases (1.5%) with D1+7 resection and 39 out of 259 cases (15.1%) with D2 resection suffered from the intestinal obstruct ion (P < 0.01). But no mortality occurred in D1+7 resection group and 2 cases (0.8%) died within one month after D2 operation.

The investigation of long-term survival showed that the survival rates of 1 and 5 years in D1+7 and D2 operation groups were respectively 98.3% vs 97.6% and 90.2% vs 92.1%, in which no significant differences could be observed.

DISCUSSION

As is well known, the degree and the range of lymphatic metastasis is dependant on the biological features of the primary tumor[10,12-14]. This study showed that one of the main risk factors for the lymphatic metastasis was the tumor invading depth infiltrating through the mucosal layer and the tumor size bei ng larger than 20 mm. In sm Ca with tumor size larger than 20 mm, the morbidity of n2 lymphatic metastasis happened with an increase in the tumor size. Therefore, correct determination of the invading depth and the tumor size are key points for the less invasive surgeries in EGC. The indications for endoscopical muco sal resection (EMR)[20-21], laparoscopic resection[22-31] and less invasive resection by laparotomy[20,32-33] should be limited in the cases of EGC without lymphatic metastasis. Even for less invasive resection by laparotomy, it should be indicated only for n1 lymphatic metastasis without ulcer, I, IIa and IIb gross types as IIc types with turnor size less than 20 mm although such indications have not been accepted ubiquitously[10,20,32-33]. The less invasive surgery by laparotomy has become one of the main choices in surgical treatment of EGC currently. The range of less invasive operation includes the partial gastrectomy and regional lymph node excision as well as the retains of the omentum, vagus, pylorus and so on[10,14,27]. The less invasive operations form Ca or sm Ca have been proven to share the good results of long-term survival[14,33], and at the same time, less invasive surgery is required.

Development of less invasive operations by laparotomy have made both MER and lap aroscopic resection applicable in the treatment of EGC[18-32]. The rate of complete resection for primary tumors and metastatic lymph nodes by EMR or l aparoscpic resection was between 45%-85%. This resection rate was lower because most tumors were larger than 10 mm and some were located in the cardia, lesser curvature of gastric body as well as latter wall of stomach [9,11,14]. M u cosal resectioning by laparoscopic surgery including lesion lefting resection[31] and gastric mucosal resection[20,23] comes in between EMR and less invasive laparotomy. Advantages of this laparoscopic surgery are to get more satisfactory resectioning of the entire layer of the gastric wall at the lesion site and the regional lymph nodes of n1 around the tumor in comparison to EMR[20,29-31]. If the tumor infiltrated to the sm Ca or the vessels in the gastric wall, the radical resectioning at the 2nd station of lymph nodes sho uld be carried out as the first choice[1,9,32,34].

Judgements for the invading depth of EGC before operation are mainly based on the gastric fiber examination with the ultrasound. On the application of the ultr a sound endoscopy, especially at 20 MHz, correct diagnostic has been observed in over 80% cases and identification of m Ca or sm Ca was easier[15-17,34]. At the same time, n2 l ymph atic metastasis happened more easily in sm Ca. Therefore, D2 lymph node excisi on should be applied in sm Ca if the diagnosis is doubtful before or during operation. The investigations on the metastasis and the regional invasion of gastric cancer has the support of not only clinicopathological studies but the genetic and molecular biological studies also[35-42]. At present, a very careful choice should be made for the less invasive operations, especially for EMR and laparoscopic surgery, as making a correct judgement for the invading depth of tumor in stomach before operation[16-17,34] is very difficult.

Footnotes

The Project Sponsored by Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Commission (1997-832)

Edited by Zhou XH proofread by Mittra S

References
1.  Noguchi Y, Imada T, Matsumoto A, Coit DG, Brennan MF. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer. 1989;64:2053-2062.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Li GF, Xie SB, Sun H, Yang XH, Liu WJ, Zhai Q, Zhou YX, Li ZH, Zhan g GM. An investigation of intra-arterial chemotherapy infu-sion and embolization combined with abdominal chemotherapy for advanced gastric cancer. World J Gastroenterol. 1998;4:71-74.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Torii A, Sakai M, Inoue K, Yamabe H, Ueda S, Okuma M. A clinicopathological analysis of early gastric cancer: retrospective study with special reference to lymph node metastasis. Cancer Detect Prev. 1994;18:437-441.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Jiang BJ, Gao YF, Sun RX, Sun H, Lu M, Tu CL. Clinical study on the dissecti on of lymph nodes around abdominal aortic artery in advanced gastric cancer. Zhongguo Putong Waike Zazhi (in press). .  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Yonemura Y, Katayama K, Kamata T, Fushida S, Segawa M, Ooyama S, Miwa K, Miyazaki I. Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node. Int Surg. 1991;76:222-225.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Uyama I, Ogiwara H, Takahara T, Kikuchi K, Iida S, Kubota T, Kumai K, Kitajima M. Spleen- and pancreas-preserving total gastrectomy with superextended lymphadenectomy including dissection of the para-aortic lymph nodes for gastric cancer. J Surg Oncol. 1996;63:268-270.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
7.  Okamura T, Tsujitani S, Korenaga D, Haraguchi M, Baba H, Hiramoto Y, Sugimachi K. Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg. 1988;155:476-480.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 125]  [Cited by in F6Publishing: 133]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
8.  Boku T, Nakane Y, Okusa T, Hirozane N, Imabayashi N, Hioki K, Yamamoto M. Strategy for lymphadenectomy of gastric cancer. Surgery. 1989;105:585-592.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Nakamura K, Morisaki T, Sugitani A, Ogawa T, Uchiyama A, Kinukawa N, Tanaka M. An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis. Cancer. 1999;85:1500-1505.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 4]  [Reference Citation Analysis (0)]
10.  Lin H, Jiang BJ, Wu T. Influencing factors on the lymph metastasis and less invasive operations in early gastric cancer. Zhongguo Putong Waike Zazhi. 1999;8:253-255.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg. 1992;79:241-244.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 259]  [Cited by in F6Publishing: 276]  [Article Influence: 8.6]  [Reference Citation Analysis (0)]
12.  Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, Sasako M, Sano T, Ochiai A, Yoshida S. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77:602-606.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 7]  [Reference Citation Analysis (0)]
13.  Zhang XY. Some recent works on diagnosis and treatment of gastric cancer. World J Gastroenterol. 1999;5:1-3.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Sakuramoto S, Hiki Y, Shimao H, Sakakibara Y, Kakita A, Kida M. Option o f treatment for early gastric cancer with regard to lymph node metastasis. Digestive Surg. 1997;20:679-689.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Lin H, Jiang BJ, Gao YF, Zhang MD, Tu CL. Application of needle type of lap aroscope in the evaluation on the end stage of digestric cancer. Zhongguo Meitan Gongye Yixue Zazhi. 2000;3:81-82.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Niwa Y, Goto H, Arisawa T, Kameyama H, Matsui M, Nomura N, Hosoi T, Haya kawa T. Endoscopic ultrasonography in the diagnosis of the depth invasion of gas tric cancer. Digestive Surg. 1997;20:691-697.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Adachi Y, Inomata M, Kitano S, Mori M, Maehara Y, Sugimachi K. Dukes' A tumor. Oncol Rep. 1997;4:1235-1237.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Tsujitani S, Kaibara N. Less invasive treatment for early gastric cancer with special reference to prognosis and quality of life of patients. Digestive Surg. 1997;20:669-677.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Yoshino K, Ogawa S. Modified surgery for gastric cancer in early stage. Digestive Surg. 1997;20:715-723.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Wu T, Jiang BJ, Tu CL. Endoscopic Surgery in early gastric cancer. Zhonghua Xiaohua Neijing Zazhi. 1998;15:123-125.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Yamashita Y, Maekawa T, Shirakusa T. Endoscopic surgery assisted open ga str ectomy with less incision in early gastric cancer. Operation. 1995;49:1301-1306.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Ohgami M, Ohtani Y, Igarashi N, Fujita K, Ishikawa H, Kubota T, Kumai K, Kitajima M. Laparoscopic surgery for mucosal gastric cancer. Digestive Surg. 1997;20:705-713.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Sakuramachi S, Kimura T, Kobayashi T. Laparoscopic surgery for early gas triccancer: Intra-luminal surgery using fine instruments. Digestive Surg. 1997;20:1453-1459.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Munakata Y, Hayashi K. Laparoscopy assisted antral gastriectomy. Digestive Surg. 1997;20:1461-1468.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Matsumoto S, Kawabe N, Suzuki K, Morishima T. Local excision of the early gastric cancer with lesion lifting method: From extraluminal approach to endol uminal approach. Digestive Surg. 1997;20:1469-1475.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Ohashi S, Oriyama T, Kanno H, Akashi A, Sasaoka H, Nishino M, Sakamaki Y, Son K. Laparoscopic intra gastric surgery for early gastric cancer. Digestive Surg. 1997;20:1477-1482.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Tanimura H, Nakai Y, Takifuji K. Laparoscopic D 1 α dissection of the perigastric lymph nodes for early cancer in the antrum or lower body of the stomach. Digestive Surg. 1997;20:1483-1490.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Shiraishi N, Adachi Y, Kitano S. Laparoscopy assisted distal gastrectomy for early gastric cancer. Digestive Surg. 1997;20:1513-1518.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Yasutake T, Ayabe H, Miura T. Laparoscopic partial gastrectomy for early gastric cancer. Digestive Surg. 1997;20:1507-1511.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Ohgami M, Ishibiki K, Kitajima M. Partial resection by laparoscope for e arlygastric cancer. Operation. 1993;47:587-597.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Matsumoto S, Kawabe N, Kawabe J. Application of lesion lifting for partial gastrectomy in early gastric cancer. Operation. 1995;49:1307-1312.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Lu M, Wu T, Jiang BJ. Less invasive resection by laparotomy in early gastriccancer without ulcer. Fubu Waike. 1999;12:189-190.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Inoue K, Tobe T, Kan N, Nio Y, Sakai M, Takeuchi E, Sugiyama T. Problems in the definition and treatment of early gastric cancer. Br J Surg. 1991;78:818-821.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 76]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
34.  Abe S, Yoshimura H, Nagaoka S, Monden N, Kinugasa S, Nagasue N, Nakamura T. Long-term results of operation for carcinoma of the stomach in T1/T2 stages: critical evaluation of the concept of early carcinoma of the stomach. J Am Coll Surg. 1995;181:389-396.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Zhao WM, Ma XH, Li ZJ, Yang CF. The effect of nitric oxide on gastric carcinoma metastasis. World J Gastroenterol. 1998;4:78-81.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Dai J, Yu SX, Qi XL, Bo AH, Xu YL, Guo ZY. Expression of bcl-2 and c-m yc protein in gastric carcinoma and precancerous lesions. World J Gastroenterol. 1998;4:84-87.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Zhan WH, Ma JP, Peng JS, Gao JS, Cai SR, Wang JP, Zheng ZQ, Wang L. Telomerase activity in gastric cancer and its clinical implications. World J Gastroenterol. 1999;5:316-319.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Zhao DC, Lu YZ, An W, Shi H, Zhao ZM. Poorly differentiated gastric neop lasm immunohistochemical analysis and significance. World J Gastroenterol. 1998;4:102-104.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Zhang L, Fu HM, Jin SZ, Zhou CG. The relation between p16 expression and biological behavior of gastric carcinoma. World J Gastroenterol. 1998;4:109-111.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Gu HP, Shang PZ, Hu HX, Li ZG, Li CG. Relationship between cell adhesion mo lecule CD15 and proliferating cell nuclear antigen (PCNA) expression in gastric cancer and precancerous lesions. World J. Gastroenterol. 1998;4:60.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Yakoob J, Hu GL, Fan XG, Zhang Z. Telomere, telomerase and digestive cancer. World J Gastroenterol. 1999;5:334-337.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Zhao WM, Ma XH, Li ZJ, Yang CF. The effect of nitric oxide on gastric carcinoma metastasis. World J Gastroenterol. 1998;4:78-81.  [PubMed]  [DOI]  [Cited in This Article: ]